These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37461958)

  • 1. P040 Latent Tuberculosis Infection In A Patient With A Negative Interferon Gamma Release Assay Prior to Biologic Initiation for Crohn's Disease.
    Masood M; Wasserman R; Nagesh V; Sifuentes H
    Am J Gastroenterol; 2021 Dec; 116(Suppl 1):S10. PubMed ID: 37461958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy.
    Ramos GP; Stroh G; Al-Bawardy B; Faubion WA; Papadakis KA; Escalante P
    Inflamm Bowel Dis; 2018 Sep; 24(10):2272-2277. PubMed ID: 29718223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Study to Monitor for Tuberculosis During Anti-tumour Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease and Immune-mediated Inflammatory Diseases.
    Lee CK; Wong SHV; Lui G; Tang W; Tam LS; Ip M; Hung E; Chen M; Wu JC; Ng SC
    J Crohns Colitis; 2018 Jul; 12(8):954-962. PubMed ID: 29757355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
    Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A
    Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom.
    Nisar MK; Rafiq A; Östör AJ
    Clin Rheumatol; 2015 Dec; 34(12):2141-5. PubMed ID: 26497501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superiority of Interferon Gamma Assay Over Tuberculin Skin Test for Latent Tuberculosis in Inflammatory Bowel Disease Patients in Brazil.
    Amorim RF; Viegas ERC; Carneiro AJV; Esberard BC; Chinem ES; Correa RS; Rodrigues L; Ribeiro-Alves M; Silva KS; de Souza HS; Carvalho ATP
    Dig Dis Sci; 2019 Jul; 64(7):1916-1922. PubMed ID: 30673986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Interferon Gamma Release Assay and Tuberculin Skin Test for Diagnosis of Latent Tuberculosis in Psoriasis Patients Planned for Systemic Therapy.
    Neema S; Sandhu S; Mukherjee S; Vashisht D; Vendhan S; Sinha A; Vasudevan B
    Indian J Dermatol; 2022; 67(1):19-25. PubMed ID: 35656280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in screening for latent tuberculosis in inflammatory bowel disease prior to biologic treatment: a UK cohort study.
    Thi AA; Abbara A; Bouri S; Collin SM; Wolfson P; Owen L; Buell KG; John L; Hart AL
    Frontline Gastroenterol; 2018 Jul; 9(3):234-240. PubMed ID: 30046428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of vedolizumab in a patient with Crohn's disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report.
    Sugiyama Y; Ueno N; Tachibana S; Kobayashi Y; Murakami Y; Sasaki T; Sakatani A; Takahashi K; Ando K; Kashima S; Moriichi K; Tanabe H; Okumura T; Fujiya M
    Medicine (Baltimore); 2023 Jul; 102(28):e34331. PubMed ID: 37443475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
    Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
    J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Interferon-Gamma Release Assay and Tuberculin Skin Test for the Screening of Latent Tuberculosis in Inflammatory Bowel Disease Patients: Indian Scenario.
    Mantri AK; Meena P; Puri AS; Kumar A; Sachdeva S; Srivastava S; Arivarasan K; Varakanahali S
    Tuberc Res Treat; 2021; 2021():6682840. PubMed ID: 33575041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biologics and mycobacterial diseases].
    Tsuyuguchi K; Matsumoto T
    Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates of latent and active tuberculosis in BGC vaccinated, immunosuppressed Crohn's disease patients form Bulgaria before and during anti-tumor necrosis factor therapy.
    Georgieva A; Atanassova A; Mirchev M
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2399-2407. PubMed ID: 35442494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis screening using IGRA and chest computed tomography in patients with inflammatory bowel disease: A retrospective study.
    Song DJ; Tong JL; Peng JC; Cai CW; Xu XT; Zhu MM; Ran ZH; Zheng Q
    J Dig Dis; 2017 Jan; 18(1):23-30. PubMed ID: 28009090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitor.
    Kwakernaak AJ; Houtman PM; Weel JF; Spoorenberg JP; Jansen TL
    Clin Rheumatol; 2011 Apr; 30(4):505-10. PubMed ID: 20737179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA-based protocol in UK subjects with inflammatory bowel disease suitable for anti-TNFα therapy.
    Greveson K; Goodhand J; Capocci S; Woodward S; Murray C; Cropley I; Hamilton M; Lipman M
    J Crohns Colitis; 2013 Jun; 7(5):412-8. PubMed ID: 23009739
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.